The International Society of Organoid Research (ISoOR) convened its 2024 annual meeting on From March 7 to 8 in Shanghai, China. The pivotal event was hosted by ISoOR in collaboration with Bioon and two more institutes to reflect on the rapid expansion of organoid industry within the country.

Prof. Hans Clevers, pioneer of organoid field, member of the National Academy of Sciences (USA) and head of Roche Pharma Research and Early Development, shared his vision around Organoids to Model Human Disease, followed by more than sixty scientific experts from around the world, to exchange insights in various sessions.

Dr. Maldonado ISoOR secretary for China region spotlighted several of ISoOR's key initiatives from the previous year, such as 2023 annual meeting in Singapore discusing latest landmarks in organoid research, and the start-point for initiation of the ISoOR Standards for Organoid Biobanks.

An organoid industry encompasses various establishments of organoids in precision medicine, drug development, regenerative medicine, organoid biobanks, policy analysis, and current trends in organoid research and applications.  Additionally, organoids and organs-on-a-chip are revolutionizing the medical industry by bringing together researchers, industry professionals, and investors with essential knowledge for navigating the field.